liu.seSök publikationer i DiVA
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Novel assay to improve therapeutic drug monitoring of thiopurines in inflammatory bowel disease
Linköpings universitet, Institutionen för medicin och hälsa, Avdelningen för läkemedelsforskning. Linköpings universitet, Hälsouniversitetet.
Skåne University Hospital, Sweden; Danderyd Hospital, Sweden.
Linköpings universitet, Institutionen för klinisk och experimentell medicin, Avdelningen för inflammationsmedicin. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Hjärt- och Medicincentrum, Magtarmmedicinska kliniken. Karolinska Institute, Sweden; Karolinska University Hospital, Sweden.
Linköpings universitet, Institutionen för medicin och hälsa, Avdelningen för läkemedelsforskning. Linköpings universitet, Hälsouniversitetet. Östergötlands Läns Landsting, Centrum för kirurgi, ortopedi och cancervård, Onkologiska kliniken US.
Visa övriga samt affilieringar
2014 (Engelska)Ingår i: Journal of Crohn's & Colitis, ISSN 1873-9946, E-ISSN 1876-4479, Vol. 8, nr 12, s. 1702-1709Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Background and aims: The thiopurines are widely used in the treatment of inflammatory bowel disease, but are limited by poor dose effect relationship. The objective was to assess the ability of a novel assay, determining the mono-, di-, and triphosphates, of thioguanine as well as methylthioinosine as individual metabolites in erythrocytes, to predict clinical outcome compared to a routine assay, determining metabolites as sums. Methods: Samples from 79 patients with Crohns disease or ulcerative colitis treated with azathioprine or mercaptopurine were analysed by both assays. Clinical status was determined by the Harvey-Bradshaw and Walmsley indices. The genotypes of thiopurine methyltransferase (TPMT) and inosine triphosphatase were determined. Results: TPMT wild-type patients with thioguanine nucleotide (TGN) levels below the cut-off level were more likely to have active disease when TGN was measured by the novel assay (p = 0.02), and when thioguanosine triphosphate (TGTP) was measured separately (p = 0.01). When TGN was measured by the routine assay the correlation was not evident (p = 0.12). Neither TGN levels nor TGTP correlated to disease activity in TPMT deficient patients. Patients with methyl thioinosine nucleotide (meTIN) levels above 1500 pmol/8 x 10less than^greater than8 RBCs were more likely to have active disease (p = 0.07). We observed good correlations between the mono-, di-, and triphosphates and their respective sums (R-2 greater than 0.88). Conclusions: The novel TGN assay was better in predicting clinical outcome compared to the routine assay, while determination of TGTP had no clinical advantage and TGTP ratio was not correlated to disease activity. (C) 2014 European Crohns and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Ort, förlag, år, upplaga, sidor
Elsevier , 2014. Vol. 8, nr 12, s. 1702-1709
Nyckelord [en]
Purines; HPLC; Inflammatory bowel diseases; Individualized medicine; Thiopurine; Azathioprine
Nationell ämneskategori
Klinisk medicin
Identifikatorer
URN: urn:nbn:se:liu:diva-113783DOI: 10.1016/j.crohns.2014.08.009ISI: 000347019600016PubMedID: 25239576OAI: oai:DiVA.org:liu-113783DiVA, id: diva2:785156
Anmärkning

Funding Agencies|Medical Research Council of Southeast Sweden (FORSS) [FORSS-161041, FORSS-235971]; Swedish Society of Medicine [SLS-178771]; County Council of Ostergotland [LIO 130231, LIO 207561, LIO 284811]; Swedish Cancer Society [CAN 2011/401]; Swedish Childhood Cancer Foundation (BCF) [12/052]; Ruth and Richard Julin Foundation; Swedish Research Council [2008-4035]

Tillgänglig från: 2015-02-02 Skapad: 2015-01-30 Senast uppdaterad: 2017-12-05

Open Access i DiVA

fulltext(477 kB)171 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 477 kBChecksumma SHA-512
fa40a3347ef2c5e8a7747f304e84d4cecdfabdc62b2314610cfaef584f51ab19061844e9acbbffec62888d654c16d7f8423da70888830079f2e5a6886451d07b
Typ fulltextMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMed

Personposter BETA

Vikingsson, SvanteAlmer, SvenPeterson, Curt

Sök vidare i DiVA

Av författaren/redaktören
Vikingsson, SvanteAlmer, SvenPeterson, Curt
Av organisationen
Avdelningen för läkemedelsforskningHälsouniversitetetAvdelningen för inflammationsmedicinMagtarmmedicinska klinikenOnkologiska kliniken US
I samma tidskrift
Journal of Crohn's & Colitis
Klinisk medicin

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 171 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 143 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf